<?xml version="1.0" encoding="UTF-8"?>
<p id="Par63">A considerable amount of rheumatology patients are on drugs that are currently being tested for prophylaxis or treatment of COVID-19. And it is difficult to predict the effects of being already on these treatments on infection rate and severity.</p>
